patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug
HYRIMOZ
Marketedupdated 2mo agoby Sandoz Inc
Approvedcommunity read0 votes
all catalysts(13)
approval · 13
Oct 30, 2018
approval
HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
HYRIMOZ
→
Feb 24, 2021
approval
HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
HYRIMOZ
→
Mar 28, 2022
approval
HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
HYRIMOZ
→
Jul 18, 2022
approval
HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
HYRIMOZ
→
Jul 18, 2022
approval
HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
HYRIMOZ
→
Mar 20, 2023
approval
HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
HYRIMOZ
→
Apr 14, 2023
approval
HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
HYRIMOZ
→
Sep 8, 2023
approval
HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
HYRIMOZ
→
Apr 5, 2024
approval
HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
HYRIMOZ
→
Jun 12, 2024
approval
HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
HYRIMOZ
→
May 20, 2025
approval
HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
HYRIMOZ
→
Jul 29, 2025
approval
HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
HYRIMOZ
→
Oct 16, 2025
approval
HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
HYRIMOZ
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that